{"id":"sialanar","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Achalasia of esophagus","Alcoholism","Anemia","Angle-closure glaucoma","Atony of colon","Autonomic dysreflexia","Benign prostatic hyperplasia","Bladder outflow obstruction","Bleeding","Brain damage","Breastfeeding (mother)","Chronic heart failure","Chronic lung disease","Complete trisomy 21 syndrome","Depressive disorder","Disease of liver","Disorder of coronary artery","Disturbance of salivary secretion","Drowsy","Drug AND/OR toxin-induced diarrhea","Dyspnea","Gastric ulcer","Gastrointestinal obstruction","Hepatic coma","Hepatic encephalopathy","Hepatic failure","Hiatal hernia","Hyperammonemia","Hypertensive disorder","Hyperthyroidism","Kidney disease","Myasthenia gravis","Myocardial dysfunction","Neutropenic disorder","Paralytic ileus","Peptic reflux disease","Poisoning by phenobarbital","Porphyria","Pregnancy, function","Pyloric obstruction","Retention of urine","Severe chronic ulcerative colitis","Sleep apnea","Spastic paralysis","Substance abuse","Suicidal thoughts","Tachyarrhythmia","Thrombocytopenic disorder","Toxic megacolon","Ulcerative colitis","Urinary tract obstruction"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":{"chemblId":"CHEMBL1201027","moleculeType":"Small molecule","molecularWeight":"398.34"},"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3"},"_scrapedAt":"2026-03-28T00:07:54.832Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Chronic obstructive lung disease","diseaseId":"chronic-obstructive-lung-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Excessive salivation","diseaseId":"excessive-salivation","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"General anesthesia","diseaseId":"general-anesthesia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Hyperhidrosis of axilla","diseaseId":"hyperhidrosis-of-axilla","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Peptic ulcer","diseaseId":"peptic-ulcer","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Vagal Reflex Bradycardia","diseaseId":"vagal-reflex-bradycardia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT04873115","phase":"PHASE4","title":"Double-blind, Placebo-controlled, Randomized Clinical Trial Comparing the Efficacy and Safety of Sialanar Plus orAl rehabiLitation Against Placebo Plus Oral Rehabilitation for chIldren and Adolescents With seVere Sialorrhoea and Neurodisabilties,","status":"UNKNOWN","sponsor":"Proveca Pharma Limited","startDate":"2021-05-10","conditions":"Sialorrhea, Neurodevelopmental Disorders","enrollment":80}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"OFF LABEL USE"},{"count":1,"reaction":"DEPRESSED LEVEL OF CONSCIOUSNESS"},{"count":1,"reaction":"DEVICE DISLOCATION"},{"count":1,"reaction":"FALL"},{"count":1,"reaction":"HIP FRACTURE"},{"count":1,"reaction":"HYPERTRIGLYCERIDAEMIA"},{"count":1,"reaction":"HYPOTHYROIDISM"},{"count":1,"reaction":"INCREASED BRONCHIAL SECRETION"},{"count":1,"reaction":"PARKINSON^S DISEASE"},{"count":1,"reaction":"PNEUMONIA"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":6,"therapeuticAreas":["Respiratory"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Sialanar","genericName":"Sialanar","companyName":"Proveca Pharma Limited","companyId":"proveca-pharma-limited","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}